118 related articles for article (PubMed ID: 22151277)
21. QSAR of Chalcones Utilizing Theoretical Molecular Descriptors.
Nandi S; Bagchi MC
Curr Comput Aided Drug Des; 2015; 11(2):184-93. PubMed ID: 26135340
[TBL] [Abstract][Full Text] [Related]
22. Discovery of new antitubercular oxazolyl thiosemicarbazones.
Sriram D; Yogeeswari P; Thirumurugan R; Pavana RK
J Med Chem; 2006 Jun; 49(12):3448-50. PubMed ID: 16759086
[TBL] [Abstract][Full Text] [Related]
23. Synthesis and in-vitro antimycobacterial activity of amino-5-[(substituted) phenyl]-3-(4-hydroxy-3-methylphenyl)-4,5-dihydro-1H-1-pyrazolylmethanethione.
Ali MA; Yar MS; Siddiqui AA; Husain A; Abdullah M
Acta Pol Pharm; 2007; 64(5):435-9. PubMed ID: 18540164
[TBL] [Abstract][Full Text] [Related]
24. Preparation and in vitro evaluation of benzylsulfanyl benzoxazole derivatives as potential antituberculosis agents.
Klimesová V; Kocí J; Waisser K; Kaustová J; Möllmann U
Eur J Med Chem; 2009 May; 44(5):2286-93. PubMed ID: 18694614
[TBL] [Abstract][Full Text] [Related]
25. Phytochemical and Antimicrobial Screening of Flavanones and Chalcones from Galenia africana and Dicerothamnus rhinocerotis.
Ticha LA; Klaasen JA; Green IR; Naidoo S; Baker B; Pietersen RD
Nat Prod Commun; 2015 Jul; 10(7):1185-90. PubMed ID: 26411007
[TBL] [Abstract][Full Text] [Related]
26. Antiviral and antituberculous activity of Helichrysum melanacme constituents.
Lall N; Hussein AA; Meyer JJ
Fitoterapia; 2006 Apr; 77(3):230-2. PubMed ID: 16529879
[TBL] [Abstract][Full Text] [Related]
27. Quantitative structure-activity relationships of mosquito larvicidal chalcone derivatives.
Pasquale G; Romanelli GP; Autino JC; García J; Ortiz EV; Duchowicz PR
J Agric Food Chem; 2012 Jan; 60(2):692-7. PubMed ID: 22217234
[TBL] [Abstract][Full Text] [Related]
28. Inhibition of Mycobacterium tuberculosis tyrosine phosphatase PtpA by synthetic chalcones: kinetics, molecular modeling, toxicity and effect on growth.
Mascarello A; Chiaradia LD; Vernal J; Villarino A; Guido RV; Perizzolo P; Poirier V; Wong D; Martins PG; Nunes RJ; Yunes RA; Andricopulo AD; Av-Gay Y; Terenzi H
Bioorg Med Chem; 2010 Jun; 18(11):3783-9. PubMed ID: 20462762
[TBL] [Abstract][Full Text] [Related]
29. New rifabutin analogs: synthesis and biological activity against Mycobacterium tuberculosis.
Barluenga J; Aznar F; García AB; Cabal MP; Palacios JJ; Menéndez MA
Bioorg Med Chem Lett; 2006 Nov; 16(22):5717-22. PubMed ID: 16987658
[TBL] [Abstract][Full Text] [Related]
30. Synthetic chalcones as efficient inhibitors of Mycobacterium tuberculosis protein tyrosine phosphatase PtpA.
Chiaradia LD; Mascarello A; Purificação M; Vernal J; Cordeiro MN; Zenteno ME; Villarino A; Nunes RJ; Yunes RA; Terenzi H
Bioorg Med Chem Lett; 2008 Dec; 18(23):6227-30. PubMed ID: 18930396
[TBL] [Abstract][Full Text] [Related]
31. Antimycobacterial activity of new 3,5-disubstituted 1,3,4-oxadiazol-2(3H)-one derivatives. Molecular modeling investigations.
Zampieri D; Mamolo MG; Laurini E; Fermeglia M; Posocco P; Pricl S; Banfi E; Scialino G; Vio L
Bioorg Med Chem; 2009 Jul; 17(13):4693-707. PubMed ID: 19467603
[TBL] [Abstract][Full Text] [Related]
32. Synthesis and
Dhivya LS; Pradeepa BR; Sarvesh S
Future Med Chem; 2022 Jun; 14(12):851-866. PubMed ID: 35548879
[No Abstract] [Full Text] [Related]
33. Antimycobacterial activity of bacteriocins and their complexes with liposomes.
Sosunov V; Mischenko V; Eruslanov B; Svetoch E; Shakina Y; Stern N; Majorov K; Sorokoumova G; Selishcheva A; Apt A
J Antimicrob Chemother; 2007 May; 59(5):919-25. PubMed ID: 17347179
[TBL] [Abstract][Full Text] [Related]
34. QSAR studies on chalcones and flavonoids as anti-tuberculosis agents using genetic function approximation (GFA) method.
Sivakumar PM; Geetha Babu SK; Mukesh D
Chem Pharm Bull (Tokyo); 2007 Jan; 55(1):44-9. PubMed ID: 17202700
[TBL] [Abstract][Full Text] [Related]
35. Antiproliferative activity of chalcones with basic functionalities.
Liu X; Go ML
Bioorg Med Chem; 2007 Nov; 15(22):7021-34. PubMed ID: 17804245
[TBL] [Abstract][Full Text] [Related]
36. N-benzylsalicylthioamides: highly active potential antituberculotics.
Dolezal R; Waisser K; Petrlíková E; Kunes J; Kubicová L; Machácek M; Kaustová J; Dahse HM
Arch Pharm (Weinheim); 2009 Feb; 342(2):113-9. PubMed ID: 19137534
[TBL] [Abstract][Full Text] [Related]
37. Measuring minimum inhibitory concentrations in mycobacteria.
Sirgel FA; Wiid IJ; van Helden PD
Methods Mol Biol; 2009; 465():173-86. PubMed ID: 20560078
[TBL] [Abstract][Full Text] [Related]
38. Synthesis, biological evaluation, and SAR study of novel pyrazole analogues as inhibitors of Mycobacterium tuberculosis: part 2. Synthesis of rigid pyrazolones.
Castagnolo D; Manetti F; Radi M; Bechi B; Pagano M; De Logu A; Meleddu R; Saddi M; Botta M
Bioorg Med Chem; 2009 Aug; 17(15):5716-21. PubMed ID: 19581099
[TBL] [Abstract][Full Text] [Related]
39. Synthesis, structure, and antimycobacterial activity of 6-[1(3H)-isobenzofuranylidenemethyl]purines and analogs.
Braendvang M; Bakken V; Gundersen LL
Bioorg Med Chem; 2009 Sep; 17(18):6512-6. PubMed ID: 19709890
[TBL] [Abstract][Full Text] [Related]
40. Structure-activity relationships on purine and 2,3-dihydropurine derivatives as antitubercular agents: a data mining approach.
Pietra D; Imbriani M; Borghini A; Giorgi I; Settimo FD; Breschi MC; Campa M; Batoni G; Brancatisano FL; Bianucci AM
Chem Biol Drug Des; 2011 Oct; 78(4):718-24. PubMed ID: 21756283
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
